Replimune (REPL) Shares Outstanding (Entity) (2017 - 2026)
Powered by 
Analysis
Replimune (REPL) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Replimune | 1.45 Bn | 1.45 Bn | - | 83.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.98 Mn |
| Mar 31, 2026 | 82.72 Mn |
| Dec 31, 2025 | 79.63 Mn |
| Sep 30, 2025 | 78.40 Mn |
| Jun 30, 2025 | 77.81 Mn |
| Mar 31, 2025 | 77.09 Mn |
| Dec 31, 2024 | 77.01 Mn |
| Sep 30, 2024 | 68.39 Mn |
| Jun 30, 2024 | 68.31 Mn |
| Mar 31, 2024 | 61.42 Mn |
| Dec 31, 2023 | 61.39 Mn |
| Sep 30, 2023 | 59.06 Mn |
| Jun 30, 2023 | 58.98 Mn |
| Mar 31, 2023 | 56.68 Mn |
| Dec 31, 2022 | 56.63 Mn |
| Sep 30, 2022 | 49.74 Mn |
| Jun 30, 2022 | 49.30 Mn |
| Mar 31, 2022 | 47.34 Mn |
| Dec 31, 2021 | 47.21 Mn |
| Sep 30, 2021 | 46.86 Mn |